Advertisement
Advertisement
U.S. markets close in 5 hours 54 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Lee Pharmaceuticals, Inc. (LPHM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.32000.0000 (0.00%)
As of 03:09PM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/6/2022
Current
Market Cap (intraday)
268.79k
Enterprise Value
7.31M
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
0.03
Price/Book (mrq)
N/A
Enterprise Value/Revenue
0.82
Enterprise Value/EBITDA
-22.23

Trading Information

Stock Price History

Beta (5Y Monthly) 876.26
52-Week Change 321.21%
S&P500 52-Week Change 3-12.09%
52 Week High 31.1900
52 Week Low 30.0001
50-Day Moving Average 30.2783
200-Day Moving Average 30.3064

Share Statistics

Avg Vol (3 month) 314.45k
Avg Vol (10 day) 321.79k
Shares Outstanding 5N/A
Implied Shares Outstanding 64.14M
Float 8N/A
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Oct 26, 1986

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2004
Most Recent Quarter (mrq)Jun 29, 2005

Profitability

Profit Margin -3.91%
Operating Margin (ttm)-8.39%

Management Effectiveness

Return on Assets (ttm)-8.34%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)8.92M
Revenue Per Share (ttm)2.16
Quarterly Revenue Growth (yoy)30.00%
Gross Profit (ttm)3.03M
EBITDA -194k
Net Income Avi to Common (ttm)-349k
Diluted EPS (ttm)-0.0840
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22k
Total Cash Per Share (mrq)0
Total Debt (mrq)7.07M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.33
Book Value Per Share (mrq)-1.41

Cash Flow Statement

Operating Cash Flow (ttm)-390k
Levered Free Cash Flow (ttm)-656.12k
Advertisement
Advertisement